Aparito - a wholly owned subsidiary of Eli Lilly and Company
Hospitals and Health CareWales, United Kingdom11-50 Employees
Aparito’s mission is to digitise clinical trials and accelerate drug development for patients with life-limiting diseases by supporting patient-centric clinical trials. We do this through our Atom5™ eCOA platform using video assessments, wearable devices and ePROs to generate continuous real-world data.